3rd Circ. Wellbutrin Ruling May Hinder Pay-For-Delay Suits
The Third Circuit's recent decision affirming a win for GlaxoSmithKline in litigation accusing the company of stifling generic competition for antidepressant Wellbutrin XL could make it much harder for drug buyers...To view the full article, register now.
Already a subscriber? Click here to view full article